[1]Vanherweghem J L, Depierreux M, Tielemans C. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet, 1993, 341: 387-391. [2]Depierreux M, van Damme B, Vanden H K. Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. American Journal of Kidney Diseases, 1994, 24: 172-180.[3]Rastaldi M P. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. Journal of Nephrology, 2006, 19(4): 407-412.[4]Vanhaelen M, Vanhaelen-Fastre R, But P. Identification of aristolochic acid in Chinese herbs. Lancet, 1994, 343:174.[5]Arlt V M, Alunni-Perret V, Quatrehomme G. Ariotolochic acid(AA)- DNA adduct as maker of AA exposure and risk factor for AA nephropathy-associated cancer. International Journal of Cancer, 2004, 111(6): 977-980.[6]Cheng J, Grande J P. Smad expression during kidney development. Experimental Biology and Medicine, 2002, 227(11): 943-956.[7]Nakao A, Afrakhte M, Moren A. Inentification of Smad7, a TGF-β- inducibe antagonist of TGF-β signaling. Nature, 1997, 389(9): 631-635.[8]Schiffer M, von Gersdorff G, Bitzer M. Smad proteins and transforming growth factor-beta singalling. Kidney International, 2000, 77: 45-52.[9]Wang Y Y, Zhang Z W, Shen H, Lu Y, Li H R, Ren X M, Wu G J. TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAⅠ. Journal of Receptor and Signal Transduction Research, 2008, 28(4): 413-428.[10]邱小波, 王 琛, 王琳芳. 泛素介导的蛋白质降解. 北京: 中国协和医科大学出版社, 2008: 23-25.Qiu X B, Wang C, Wang L F. Ubiquitin-Mediated Proteolysis. Beijing: Press of China Union Medical University, 2008: 23-25. (in Chinese) [11]Gondi C S, Rao J S. Concepts in vivo siRNA delivery for cancer therapy. Journal of Cellular Physiology, 2009, 220(2): 285-291.[12]Brummelkamp T R, Bernards R, Agami R. A system for stable expression of short interfering RNAs inmammalian cells. Science, 2002, 296(5567): 550-553.[13]Weber M, Moller K, Welzeck M. Effects of lipolysaccharide on transfection efficiency in eukaryotic cells. Biotechniques, 1995, 19: 930-940.[14]Elbashir S M, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22- nucleotide RNAs. Genes and Development, 2001, 15: 188-200.[15]Livak K J, Schmittgen T D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-△△Ct method. Methods, 2001, 25(4): 402-408.[16]唐永凯, 贾永义. 荧光定量PCR 数据处理方法的探讨. 生物技术, 2008,18(3): 89-91.Tang Y K, Jia Y Y. The processing method study of real-time PCR data. Biotechnology, 2008, 18(3): 89-91. (in Chinese)[17]Derrick G, Olivier V. Control of RNA silencing and localization by endolysosomes. Trends in Cell Biology, 2010, 20(8): 491-501.[18]Berns K, Hijmans E M, Mullenders J. A large-scale RNAi screen in human cells identifies new components of the p53 pathways. Nature, 2004, 428: 431-437.[19]Bantounas I, Phylactou L A, Uney J B. RNA interference and the use of small interfering RNA to study gene function in mammalian systems. Journal of Molecular Endocrinology, 2004, 33: 545-557. [20]Jin H L, Hongjian Z, Xiao H. Smad7 inhibits fibrotic effect of TGF-beita on renal Tubular epithelial cells by blocking Smad2 activation. Journal of the American Society of Nephrology, 2002, 13(6): 1464-1472.[21]Mohammed A, John J. R, Dongho K. Approaches for chemically synthesized siRNA and vector-mediated RNAi. FEBS Letters, 2005, 579(26): 5974-5981.[22]Elbashir S M, Harborth J, Lendecke W. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 2001, 411(66): 494-498.[23]Ramaswamy G, Frank J S. siRNA: a guide for RNA silencing. Chemistry and Biology, 2002, 9(10): 1053-1057.[24]Hirohiko H. Enhancement of RNAi activity by improved siRNA duplexes. FEBS Letters, 2004, 557(1/3): 193-198.[25]Liu F Y, Li X Z, Peng Y M. Arkadia regulates TGF-beta signaling during renal tubular epithelial to mesenchymal cell transition. Kidney International, 2008, 73(5): 588-594.[26]Wicks S J, Haros K, Maillard M. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene, 2005, 24(54): 8080-8084.[27]Wicks S J, Grocott T, Haros K. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. Biochemical Society Transactions, 2006, 34(5): 761-763. |